BREAST CANCER BRACHYTHERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Breast Cancer Brachytherapy Market, By Technology (High Dose Rate (HDR) Brachytherapy and Low Dose Rate (LDR) Brachytherapy), By Application (Early Stage Breast Cancer, Recurring Breast Cancer, and Others), By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In May 2024, Artemis Hospital in Delhi NCR, India, introduced a Brachytherapy program, offering patients minimally invasive cancer treatments that deliver targeted radiation while preserving healthy tissues
In May 2024, the University of Texas’ MD Anderson Cancer Center announced significant progress, including an antibody-drug conjugate for breast cancer that demonstrated clinical efficacy and safety, along with ongoing research to enhance brachytherapy treatment options
In October 2023, iCAD, a medical device company sold its Xoft brachytherapy division to Elekta, a cancer care company, for approximately USD 5.5 million, enabling Elekta to expand its range of radiation therapy options and improve access to brachytherapy treatments